{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:57:04Z","timestamp":1788965824751,"version":"build-2803163510"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Gastroenterol."],"abstract":"<jats:sec><jats:title>Aim<\/jats:title><jats:p>The issue of transplant-free survival rate (OS) among patients with primary biliary cholangitis (PBC) remains a persistent concern. In predicting the long-term OS of PBC patients, given the complexity and population specificity of models such as the GLOBE and UK-PBC, our objective is to calculate and assess the risk factors for mortality and 5-year OS among PBC patients based on routine clinical data, ultimately facilitating its clinical application.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study enrolled 315 patients with PBC from Beijing Ditan Hospital and randomly divided them into a training cohort (n = 189) and a validation cohort (n = 126). Through Cox regression analyses, we identified risk predictors of mortality to develop a 5-year survival nomogram for PBC. The model was evaluated with Receiver Operating Characteristic (ROC) curves, calibration curves, Decision Curve Analysis (DCA).Kaplan-Meier (KM) curves compared OS across risk groups. Additionally, correlations among the indicators were analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Ultimately, we established a nomogram incorporating Age, NLR, and TBIL. The Area Under the ROC Curve(AUC-ROC) values for the training and validation groups were 0.7251 and 0.7721, respectively, indicating solid consistency and outperforming the GLOBE model. Calibration and DCA curves further underscored the clinical utility of our model.KM curves revealed the model could differentiate OS across risk levels in subgroup. Additionally, a significant correlation between NLR and TBIL (P=0.0021) was observed, potentially impacting patient prognosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We have constructed a well-performing prognostic model based on Age, NLR, and TBIL. This model shows good discrimination, consistency, and clinical use. It helps identifying high-risk patients, enabling more frequent follow-ups and tailored interventions, potentially enhancing prognosis and clinical outcomes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fgstr.2025.1534145","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T11:17:07Z","timestamp":1741778227000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk factors for mortality in patients with primary biliary cholangitis: a nomogram to predict 5-year survival"],"prefix":"10.3389","volume":"4","author":[{"given":"Yaxing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muyu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiqin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12016-017-8656-x","article-title":"Geoepidemiology of primary biliary cholangitis: lessons from Switzerland","volume":"54","author":"Terziroli-Beretta-Piccoli","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cholangitis","volume":"386","author":"Carey","year":"2015","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13448","article-title":"Population-based epidemiology of primary biliary cirrhosis in South Korea","volume":"43","author":"Kim","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2017.43","article-title":"Epidemiology and natural history of primary biliary cholangitis in the Chinese: A territory-based study in Hong Kong between 2000 and 2015","volume":"8","author":"Cheung","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14521","article-title":"Prognosis of 732 ursodeoxycholic acid-treated patients with primary biliary cholangitis: A single center follow-up study from China","volume":"34","author":"Chen","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.322476","article-title":"Neutrophil-to-lymphocyte ratio in sporadic amyotrophic lateral sclerosis","volume":"17","author":"Wei","year":"2022","journal-title":"Neural Regener Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2017.10.024","article-title":"Age and immunity: what is \u201cimmunosenescence\u201d","volume":"105","author":"Pawelec","year":"2018","journal-title":"Exp Gerontol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0180-1","article-title":"Mechanisms underlying T cell ageing","volume":"19","author":"Goronzy","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41575-020-0342-4","article-title":"Liver regeneration: Biological and pathological mechanisms and implications","volume":"18","author":"Michalopoulos","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1142177","article-title":"Prevalence and prognostic significance of main metabolic risk factors in primary biliary cholangitis: a retrospective cohort study of 789 patients","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cgh.2017.12.033","article-title":"Increasing prevalence of primary biliary cholangitis and reduced mortality with treatment","volume":"16","author":"Lu","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2017.05.006","article-title":"Geoepidemiology, clinical manifestations and outcome of primary biliary\u00a0cholangitis in Greece","volume":"42","author":"Gatselis","year":"2017","journal-title":"Eur J Intern Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2022.03.002","article-title":"Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma","volume":"54","author":"Giannini","year":"2022","journal-title":"Dig Liver Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000179","article-title":"Primary biliary cholangitis: epidemiology, prognosis,\u00a0and treatment","volume":"7","author":"Trivella","year":"2023","journal-title":"Hepatol Commun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4149\/BLL_2021_078","article-title":"Neutrophil-to-lymphocyte ratio, past, present and future perspectives","volume":"122","author":"Zahorec","year":"2021","journal-title":"Bratisl Lek Listy"},{"key":"B19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/cncr.32506","article-title":"High neutrophil-to-lymphocyte ratio (NLR) is associated with treatment failure and death in patients who have melanoma treated with PD-1 inhibitor monotherapy","volume":"126","author":"Bartlett","year":"2020","journal-title":"Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.21564","article-title":"Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitis","volume":"27","author":"Celikbilek","year":"2013","journal-title":"J Clin Lab Anal"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic\u00a0review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"B23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cllc.2015.07.007","article-title":"Pretreatment immune parameters predict for overall survival and toxicity in early-stage non-small-cell lung cancer patients treated with stereotactic body radiation therapy","volume":"17","author":"Shaverdian","year":"2016","journal-title":"Clin Lung Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.09.001","article-title":"Pretreatment neutrophil-to-lymphocyte ratio predicts survival and liver toxicity in patients with hepatocellular carcinoma treated with stereotactic ablative radiation therapy","volume":"109","author":"Lo","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-20-997","article-title":"Preoperative peripheral\u00a0blood neutrophil-to-lymphocyte ratios (NLR) and platelet-to-lymphocyte ratio (PLR) related nomograms predict the survival of patients with limited-stage small-cell lung cancer","volume":"10","author":"Chen","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.5009\/gnl18271","article-title":"Prognostic value of biochemical response models for primary biliary cholangitis and the additional role of the neutrophil-to-lymphocyte ratio","volume":"12","author":"Yoo","year":"2018","journal-title":"Gut Liver"},{"key":"B27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","article-title":"The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis","volume":"128","author":"Corpechot","year":"2005","journal-title":"Gastroenterology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00699.x","article-title":"Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients","volume":"101","author":"ter Borg","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i19.5746","article-title":"Pathogenic role of oxidative and nitrosative stress in primary biliary cirrhosis","volume":"20","author":"Grattagliano","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","article-title":"Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy","volume":"149","author":"Lammers","year":"2015","journal-title":"Gastroenterology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1053\/j.gastro.2014.08.029","article-title":"Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study","volume":"147","author":"Lammers","year":"2014","journal-title":"Gastroenterology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28017","article-title":"The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis","volume":"63","author":"Carbone","year":"2016","journal-title":"Hepatology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-315259","article-title":"The British Society of Gastroenterology\/UK-PBC primary biliary cholangitis treatment and management guidelines","volume":"67","author":"Hirschfield","year":"2018","journal-title":"Gut"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510230532","article-title":"Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis","volume":"23","author":"Kilmurry","year":"1996","journal-title":"Hepatology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22517","article-title":"Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay","volume":"48","author":"Mayo","year":"2008","journal-title":"Hepatology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000002029","article-title":"Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool","volume":"33","author":"Murillo Perez","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7111445","article-title":"The proinflammatory cytokines IL-18, IL-21, and IFN-\u03b3 Differentially regulate liver inflammation and anti-mitochondrial antibody level in a murine model of primary biliary cholangitis","volume":"2022","author":"Xu","year":"2022","journal-title":"J Immunol Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S430730","article-title":"The role of inflammation in cholestatic liver injury","volume":"16","author":"Chen","year":"2023","journal-title":"J Inflammation Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26322","article-title":"Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: results of a 14-year cohort study","volume":"58","author":"Zhang","year":"2013","journal-title":"Hepatology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000557","article-title":"Goals of treatment for improved survival in primary biliary cholangitis: treatment target should be bilirubin within the normal range and normalization of alkaline phosphatase","volume":"115","author":"Murillo Perez","year":"2020","journal-title":"Am J Gastroenterol"}],"container-title":["Frontiers in Gastroenterology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgstr.2025.1534145\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T11:17:09Z","timestamp":1741778229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgstr.2025.1534145\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":40,"alternative-id":["10.3389\/fgstr.2025.1534145"],"URL":"https:\/\/doi.org\/10.3389\/fgstr.2025.1534145","relation":{},"ISSN":["2813-1169"],"issn-type":[{"value":"2813-1169","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"article-number":"1534145"}}